Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,639 INR | -2.90% | +1.83% | +23.96% |
05-13 | Lupin Relaunches Mirabegron ER Tablets in US | MT |
05-09 | Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.96% | 9.21B | |
+29.98% | 682B | |
+31.90% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.53% | 240B | |
+9.39% | 209B | |
-8.79% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan